Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Haemonetics 4th Quarter Fiscal 2018 Earnings Release Available on Investor Relations Website

Haemonetics Corporation
Posted on: 08 May 18
Haemonetics 4th Quarter Fiscal 2018 Earnings Release Available on Investor Relations Website Financial release accessible online

PR Newswire

BRAINTREE, Mass., May 8, 2018

BRAINTREE, Mass., May 8, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter and fiscal year ended March 31, 2018 are available on its Investor relations website.

The Company is posting this press release and, additionally, results tables that will be referenced on its webcast to its Investor Relations website. 

Direct link to Earnings Release 4Q and FY18:

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDAzOTQxfENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636606959488540250

Direct link to Results Tables 4Q and FY18 That Will Be Referenced on Webcast:

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDAzOTQ4fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636606959488540250

As previously announced, the Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8:00am Eastern Time on May 8, 2018. The call can be accessed with the following information:

  • U.S. / Canada toll free (877) 848-8880; International (716) 335-9513 Conference ID required for access: 4077509.
  • A live webcast of the call can be accessed on Haemonetics' investor relations website.  
    Direct link to Conference Call Webcasthttps://edge.media-server.com/m6/p/wcre57f8.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.      

Investor Contact

Media Contact      

Gerry Gould, VP-Investor Relations        

Carla Burigatto, VP-Communications 

(781) 356-9402                                  

(781) 348-7263  

gerry.gould@haemonetics.com              

carla.burigatto@haemonetics.com  

   

View original content with multimedia:http://www.prnewswire.com/news-releases/haemonetics-4th-quarter-fiscal-2018-earnings-release-available-on-investor-relations-website-300643867.html

SOURCE Haemonetics Corporation

PR Newswire
www.prnewswire.com

Last updated on: 08/05/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.